Meta analysis refers to secondary data analysis where information from individual research articles are synthesised to arrive at a summary estimate. Meta analysis thus refers to several related steps of framing a question or a problem, formulating search strategies, collection of journal articles or primary studies, abstraction of data from the studies, critical appraisal of studies, judging homogeneity of studies, and synthesis of information from them. In this paper, we describe the key processes of how to conduct each of these steps to conduct a meta analysis.
These steps of meta analysis indicate that a range of skills are needed and meta analysis therefore is a multi-disciplinary team based activity. Consider for example, that you are planning to conduct a meta analysis for available evidence on the effectiveness of meditation plus medications as opposed to medications alone for the control of hypertension. In order to conduct such a meta analysis, you will need the skills of a physician who is knowledgeable about management of hypertension, but also of an expert who can advise on mindfulness meditation, an expert who can conduct literature search on the topic, and a statistician who can statistically combine data for arriving at a summary estimate. In addition, you will need researchers who can maintain a database full of articles, and abstract data from the articles for further processing. In summary, meta analysis is an interdisciplinary team work. Framing of a research question include domain knowledge and skills, while at the same time, critical appraisal of the studies to identify risks of biases will need skills where the researcher should not allow domain knowledge to be biased at conclusions of specific studies. Therefore a study team should include both experts and non-experts. Given the "explosion" of information in literature and research studies, search of literature to narrow down to the exact quanta of literature needed for a successful meta analysis will need inclusion of a person with skills of literature search (a health information specialist can bring on board such skills). Hence before a meta analysis can be conducted, it is important for the analyst to put together a team consisting of individuals at least the following set of skills:
1. One or more domain experts who can identify and scope the health problem of interest 2. A health information specialist who will bring on board skills of literature search and retrieval of studies 3. A statistician who will analyse complex data from the studies as studies can present data in different ways and often sophistical statistical skills are required in identifying or estimating key data elements for meta analysis 4. A database expert who can store and curate records or bibliography records Also, since meta analysis is based on previously conducted studies and studies whose results have already been obtained, this is necessarily retrospective. Besides, in a intervention [I] or exposure [E] depending on whether the meta analysis is about interventions to be tested against each other or whether the meta analysis being conducted is about association of a specific exposure (against another) for a particular outcome; comparator [C] -who or what is being compared with the intervention or the exposure under study, and finally outcome [O] -the specific health outcome of interest, in that order. The role of participants is important in meta analysis as the same topic can result in different research questions depending on the participant profiles. For example, if your interest is in studying the risks of hormone replacement therapy for breast cancer, the studies can be very different depending on whether you are only going to be interested in pre-menoupausal or post menopausal women (age as participant character become important). Similarly if you are interested to study roles of antihypertensive therapy, gender can be an important variable. The intervention or exposure will need to be specified as the scope and relevance of a meta analysis, and often, whether a meta analysis can at all be attempted, depend on how broadly or how tightly the intervention is defined. For example, imagine you are planning to conduct a meta-analysis comparing a combination of mindfulness meditation based stress reduction and drugs with drugs alone for the control of stress related symptoms among breast cancer survivors. While this is a well-defined intervention in itself, the number of studies that you can identify may be limited. On the other hand, you could retrieve a larger number of primary studies if you were to relax the intervention to include "any form" of meditation rather than MBSR. Then again, you would have to sacrifice homogeneity of studies (loosely, similarity of studies, explained later) and in turn, this consideration alone might lead to a different form of summarisation rather than conducting a meta analysis; for instance, you could shape up the review not as a metaanalysis but as an omnibus review or an overview of the effectiveness of any form of meditation for the control of hypertension. You might have to abandon a meta analysis and end up doing a systematic or narrative review. Therefore, precision in the definition of intervention or exposure criteria can be a major decider for the meta analysis.
Likewise comparators and outcomes to be studied for a research are crucial to its success.
An Example of PICO formatted research question (Table 1 ). - Table 1 shows the PICO criteria for a meta analysis of the effectiveness of mindfulness based stress reduction for control of hypertension among elderly (64+ year old) hypertensives Table 1 . Explanation of PICO Too Narrow versus Too Broad Meta Analysis. -Framing of the research question sets the tone for a meta analysis. A meta analysis can be very narrow in scope; a too narrowly defined meta analysis can result in retrieval of too few studies. Scoping a meta analysis is not necessarily an easy task as this involves taking into consideration several factors: availability of supporting information, background data on the problem being studied, composition of the team and resources, and also the potential impact of the meta analysis on the problem being studied (cite the Higgins review). If the meta analysis is too narrow, then the results cannot be generalised to larger population. For instance, generalisability of the results is a problem with randomised controlled trials as they tend to be very specific, and using few randomised controlled trials in a meta analysis may not be very helpful for generalisation of the study findings. This is almost akin to conducting a subgroup analysis in a meta analysis where only a select subgroup of available studies are considered; additionally, too narrowly focused meta analysis often results in selection bias of studies particularly with experts who are prone to exclude studies that do not meet their inclusion and exclusion criteria as these are very tightly defined.
Condition

Definition or Explanation
On the other hand, if the meta analysis is too broadly defined, it becomes a very time consuming exercise, as the number of search results are very large, and takes time to analyse the volume of studies that are retrieved. Additionally, as studies would be very diverse, risks of studies being heterogeneous is high, and in turn leads to problems of interpretation of data. Large number of studies that are dissimilar to each other because of the diversity and over inclusive nature of the search results in what is often referred to as "mixing of apples and oranges". In a tutorial on conducting Cochrane Reviews, Higgins et.al.(2000) have stated that such mixing is fine when the object of the study is to know about "fruits" but not when finer characterisation about either apples or oranges is the objective of the study [5] . Given this dilemma, a possible middle path for a large or broad based question might be to start with a series of smaller meta analyses that compare only two conditions or two interventions at a time and subsequently adding the studies to a thematic whole so that the overall large topic can be addressed from a robust methodological perspective.
Step Two: Searching Literature
After a study question is framed, the meta analyst then proceeds to conduct a search of the literature databases. The exact phrases and combinations of words used to search the databases depend on the criteria already set up in the scoping of the meta analysis. In Use of Boolean expressions of AND (narrows down the searches to only specific terms), OR (expands the searches to include all the terms or phrases used), NOT (excludes the searches and narrows down to specific terms) are used along with wildcard entries (Table 2) . A common strategy for searching of articles is to start with terms describing "outcomes" first, then adding terms describing the "intervention" or "exposure" related terms, and finally terms that define or describe the "study design" related terms. For example, if you were to search for all studies on mindfulness based meditation and control of hypertension, you might start with "hypertension" or "high blood pressure"; then follow up the search with "mindfulness based meditation", and then terms descriptive of "randomised controlled trials" or "controlled clinical trials". Finally, use of years, and languages often limit the searches. In addition to manually constructing search terms, the researchers also frequently make use of specialised search terms and combinations of search terms that are made available for specifically conducting searches. Specifically, researchers who conduct Cochrane Reviews can avail of the services offered by the Cochrane Trialists or Cochrane Coordinators who maintain and curate databases of search terms that are validated for specific types of studies to be retrieved and these are used (cite the website). findings and therefore not included in the meta analysis, the meta analysis would itself be biased and would result in potentially erroneous estimates. Therefore, the meta analyst must conduct an active search for all publications and data which may not have been published or otherwise in archives or in authors' personal collection which although the research was completed still remained unpublished. Such publications are known as "grey literature" and must be included in any meta analysis. While it is not easy to retrieve such publications, usually contact with known experts, and active searching of conference abstracts, contacting first authors, or searching of trial registers are warranted to identify these sources of information. Omission of grey literature leads to "publication bias" (also referred to as "file drawer problem") meaning that articles or publications that are otherwise publishable (they are well conducted trials of good quality of evidence) but they never see the light of day (and consequently likely to be confined to the file drawers of the individual investigators for a variety of reasons.
Perhaps the articles submitted to the journal are rejected because the editors of the journals do not have any interest in publishing negative findings, or the investigator decides not to send such articles to any journal as the journal is perceived not to publish them. Irrespective of the reason, publication bias must be formally examined during meta analysis. At present, rather than formal testing of the extent of publication bias, visual methods such as construction of "funnel plots" are available and should be reported in any meta analysis.
Besides reporting of publication bias, the reference lists of all the retrieved articles must be read and then the titles and abstracts of each reference article on that list should be read and attempt must be made to identify additional studies. This is known as "hand searching" and involves searching where necessary library archives or paper copies of journal articles. Thus, in summary, searching for publications involve teamwork, careful construction of search filters and algorithms, and is a recursive process where the articles are searched exhaustively till a number of studies are finally retrieved that can answer the research question. 
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Risk of Bias Appraisal of Full Texts
In meta analysis, data from primary studies are combined to arrive at a summary estimate of the association between two variables. Where the objective is to estimate the overall effectiveness of a particular treatment, this process involves pooling results from primary studies to arrive at a summary estimate to assess whether compared with alternative treatments or placebos or compared with no treatment at all, the treatment under review was effective in achieving the outcomes set out in the studies. For observational studies, the aim is to assess whether the pooled estimates of the odds ratios or relative risk estimates indicate a valid association between the two entities. It follows that in meta analysis, the analyst is not only interested in the presence of the evidence but also whether the evidence is comparable across the studies included in the meta analysis. As a result, if the studies themselves are of poor quality, then the overall quality of the meta analysis will not only be poor, it may also end up propagating the errors that compromise internal validity in primary studies.
In order to establish internal validity of a trial or an observational study, the investigators of studies should address three related entities -play of chance (the study should have sufficient number of participants to rule out random association), biases that can arise in course of conducting the study, and controlling for confounding variables.
As an example, consider an investigator who is interested to study the association between excessive coffee drinking and the risk of pancreatic cancer and decides to conduct a case control study of individuals with and without pancreatic cancer and will measure their coffee consumption and with this measurement, the investigator will investigate whether excessive coffee consumption as defined under conditions of the study is associated with pancreatic cancer. In order to establish internal validity in such a study, she must specify ahead of conducting the study how many participants should be 4. Detection Bias. -Systematic differences in which the outcomes are assessed.
In review of randomised controlled trials, it is essential to critically examine how participants were allocated to treatment and alternative conditions and how such allocations were concealed from not only the participants in the study but also for investigators. Such concealment is referred to "blinding" or "allocation concealment".
Studies that fail to demonstrate robust processes of allocation concealment are likely to report significant selection biases or reporting biases and therefore these studies are at significant risk of studies with inaccurate estimations of the extent of associate between the treatment and outcomes.
Step Four: Abstract Data from Individual Studies Abstraction of data from individual study is critical for data analysis, and the process is now fairly standardised when specific summary of findings forms (SoF forms) are used.
These forms have been developed by the GRADE Working Groups and provide detailed instructions as to how to use the data abstraction forms. These forms are also standard components of software such as RevMan Software used to conduct meta-analysis published by the Cochrane Collaboration. In general, the abstraction of information from primary studies include the first (or corresponding) author of the study, the year the study was reported, the population on which the study was conducted, the intervention or the exposure that was studied, and comparison groups, the outcomes, the effect estimates, and elements of information that indicate quality of the study. In general, the Cochrane Handbook recommends the following elements of data to be abstracted: admission to discharge between intervention and control arm participants, then that outcome is a "time-to-event" outcome. Similarly, in cohort studies, often investigators are interested to study the length of time before the first case of disease appear following exposure (and those who were not exposed to specific exposure variables). Here as well, the length of time to the emergence of disease in participants is considered as a "time-to-event" outcome. In this chapter, we shall discuss binary and continuous outcome but skip other outcomes ("time to discharge" and ordinal outcomes") as beyond the scope for this chapter.
How to abstract Data for binary outcomes and continuous outcomes
For abstraction of data from binary outcome variables, it is helpful to construct a two by two table and fill in the cells as follows: with pravastatin and 36.4% with atorvastatin. Based on this information alone, the risk Exposure/Intervention Did Not Occur C D difference for reduction of C-reactive protein was 36.4% -5.2% = 31.2% and favoured atorvastatin over pravastatin. When translated to numbers needed to treat, this would indicate about 3 patients would be needed to be treated with atorvastatin (compared with pravastatin) to register one additional person's benefits for C-reactive protein [6] .
In cases where outcomes variable is "continuous", two measures are mean difference and standardised mean difference. The formulae for these two measures are as follows:
Mean Difference = Mean of the outcome variable for participants in the treatment arm - In general, different software packages are used for meta analysis, and these software packages often specify the level of outcome variable and entities required for analysis.
For example, in the popular software package STATA, if you conduct meta analysis using the routine referred to as "metan", you will need to provide either three variables, A common problem is that, often study authors present data in the form of numbers of participants, relative risk estimates and p-values alone, rather than providing the readers data enough to abstract the numbers of participants in each arm to enable construction of two by two tables for the concerned study. In these cases, depending on the sample size presented, either z-values or t-values are estimated and then from these estimates standard deviations are worked out (these are the situations where statistical advices become essential to proceed). In other instances, you can easily construct a two by two table for some studies, while for others, authors may present only risk ratio estimates with 95% confidence intervals indicating lower and upper limits of the confidence intervals and the number of participants in the study (in each arm). In these cases, the analyst needs to estimate the point estimates of effect and associated standard deviation (SD), but all studies for the meta analysis should use the same measures. If in some studies report relative risks and other studies report numbers that would enable estimation of two by two tables, then for all studies relative risks are reported along with standard deviations to estimate the summary effect measure.
Step Five: Assess Whether the Studies are Homogeneous
In a meta-analysis, the researchers answer the following three questions:
1. What is the overall (summary) relationship between the treatment/intervention/ exposure and the health outcomes? Or put in another way, is there evidence that the intervention is associated with the outcomes under study?
2. Is this association consistent across the studies that constitute the meta analysis?
3. Are all studies that would have been captured contribute to the pooling of results?
Is there a bias introduced in the way studies were collated to introduce selection bias because of the way studies were selected for publication (publication bias)?
The first two questions are addressed in a meta analysis by pooling of data from studies and by statistically testing for the presence of heterogeneity in the study findings.
In general, when a meta-analysis is conducted, a number of different studies with diverse populations and different measures are included. These studies are based on different population and as such are different from each other in several respects (they do share commonalities such as study design, and study aims and objectives). As a result, although studies are so selected to have very similar interventions (as a matter of fact, identical or same interventions or same exposures) and outcomes (health outcomes), there can still be differences in profiles of participants or differences in the quality of the studies, or the methods used in the studies. The differences in the participant profiles are known as "clinical heterogeneity" and differences in the method of execution of the studies themselves are known as "methodological heterogeneity".
Beyond these two sources of heterogeneity, variability is also observed in the magnitude and direction of the effect size between the intervention or exposure and health outcomes. This diversity is referred to as statistical heterogeneity and refers to the extent analysis. As long as these differences are so small that they do not statistically significantly differ from a centrally pooled estimate, these studies are known as "statistically homogenous". Such homogeneity can be tested commonly in two ways:
1. Simple chi-square test of homogeneity. -Here, the number of studies are tested in a framework of hypothesis testing. The null hypothesis states that the effect sizes of individual studies are same, while the alternative hypothesis states that the effect sizes are different from each other (heterogeneity). In the chi-square test (the measure is also known as "Cochran's Q") with N -1 degrees of freedom (where N = number of studies included in the meta analysis) provides a measure of heterogeneity. If the p-value is less than 0.05 (or less than 0.10 or a prespecified cut-off), then the studies are considered to be statistically heterogeneous.
However, measurement of heterogeneity in this manner has the problem that if the meta analysis includes a large number of studies, then the chance of statistical heterogeneity also proportionately increases even if the studies are similar to each other to a large extent. To address these concerns, another test, I-square test of heterogeneity is used. if there are large number of studies, then the p-value can be less than the cut off yet the studies may be homogeneous [5] .
What Happens When the test of homogeneity fails. -
In case of statistically significant heterogeneity, the analyst must explore features of studies that explain such heterogeneity. This can be done through careful review of the methods and results of individual studies or studies in groups; also, analysis of subgroups of studies based on predefined criteria (also quality assessments) are important. A common statistical way to conduct subgroup analyses is to conduct metaregression, where the pooled effect estimate is regressed on identified features of the studies and searched for regression lines that explain how individual study features might be associated with the variability in the effect estimates.
In case of significant heterogeneity where there are also significant differences in the directions of the effect estimate, an average estimate of the effectiveness may be misleading (for example, imagine conducting a meta analysis on the effectiveness of an intervention on survival for post-operative patients; now, in that meta analysis, you found statistical heterogeneity; over and above, some studies indicate that interventions have protective effects on the survival (that is, they increase survival) while other studies indicate that the interventions actually increase the risk of death or reduce the survival probability). In this situation, a meta analysis is best not conducted by statistically pooling data from the studies, but a narrative review can be attempted to summarise the key features of the studies and summarise study findings; also, a systematic review need not contain meta analysis. It is sufficient to conduct a narrative synthesis of data and explore the causes of such heterogeneity. Another option might be to perform a random-effects meta analysis -the studies are assumed to be part of a "universe of similar studies" and therefore this meta analysis can accommodate the fact that the studies can be so dissimilar with each other that their effect sizes may vary significantly. In summary, in presence of statistical heterogeneity, in all cases, an exploration of the causes of heterogeneity should be attempted, using subgroup analysis;
additionally, if there is also additional variability in the direction of the effect measures, then it is best not to pool the study results but conduct a thorough exploration of the causes of such heterogeneity. In case where the direction of effect measures do not vary, in addition to exploration of the causes of such heterogeneity, a random effects meta analysis may be conducted.
Step Six: Conduct Fixed Effects or Random Effects Meta Analysis
In those situations where formal statistical pooling of the study results are warranted, the goal of meta analysis is to arrive at a summary measure of the overall effect estimate based on individual study effect sizes. These individual studies are obtained based on for meta analysis, we pool only results of diastolic blood pressure differences between
Blacks and Whites and conduct a meta analysis. We presume that the initial steps of meta analysis, framing of research question, searching of the literature, identification of the studied, and critical appraisal of the studies themselves and identification of the risk of bias were all completed so these are not repeated [7] . Here, we are interested in three aspects of meta analysis: 3. Is there a significant publication bias in the studies?
We first test whether the studies were sufficiently homogeneous or whether the studies were grossly heterogeneous. The readers are encouraged to read the main meta analysis (see reference section), but in this case, our interest is only on statistical tests of heterogeneity. We note that otherwise in terms of recruitment of the participants, the methodology of research, the studies were similar (that is, the studies were clinically and methodologically similar). Let's review the statistical tests of heterogeneity:
• To answer whether the meta analysis was based on all relevant studies, evidence of publication bias is tested using a funnel plot (the boundaries of such a plot takes the shape of an upturned funnel, hence the name). A more formal statistical test is not available for further analysis of this graph. The above graph demonstrates a funnel plot.
As can be seen in this plot, weighted mean differences in the diastolic pressures of the two groups are plotted on the X-axis and standard error of the mean differences are plotted on the Y-axis. This is done to check visually whether a pattern can emerge such that small or negative studies that are either missed or disproportionately presented in that matrix that would otherwise be present. The mouth of the funnel points downwards where studies that are of low power are presented (they are considered to be of low power as the standard error is quite high and hence they are located to the bottom of the Y axis), but note as well that because of this, we'd expect that the positive and negative studies will be fairly evenly distributed. As the power of the studies will increase, we'd expect that the studies will converge towards the summary estimate that we have seen were not omitted in this meta analysis. This indicates publication bias in this study.
As in this meta analysis, we noted heterogeneity, therefore a subgroup analysis of the studies is important. While subgroup analyses can be conducted in different ways and indeed, in the study the authors reported subgroup analyses, one common strategy is to conduct a subgroup analysis by conducting a regression analysis. In the linear regression analysis, referred to as "meta regression", the subgroup can be considered on any study In this meta analysis, given the heterogeneity of the studies in finding the association between ACE inhibitor dosage and response for diastolic blood pressure, a reanalysis was done. In the reanalysis of the, the effect size of the studies was regressed on the In general, in deciding to conduct meta analysis, it is important to keep in mind the comprehensiveness of the search process and the heterogeneity of the studies included in the meta analysis. This is where a decision whether to conduct meta analysis or not at all need to be made. Assessment of study heterogeneity is particularly important. Moher In this chapter, the emphasis was on conducting pairwise meta analyses using a standard approach of identifying studies that compare only two interventions or only two exposure conditions for the same outcome. Newer approaches to meta analyses also include network meta analyses where more than one intervention or one exposure for a range of outcomes (or a matrix of interventions and outcomes are studied). However, a detailed discussion of network meta analyses is beyond the scope of this review. A place to start while embarking on a meta analysis is Cochrane Collaboration (http:// www.cochrane.org) which is a rich repository of meta analyses and systematic reviews on a range of topics. Cochrane Collaboration also provides training and offers a free software package to manage systematic reviews and meta analyses easily -the Revman package. While Revman software allows organisation and conduct of meta analysis easy, for additional analyses, statistical software packages such as R and Stata have several packages and routines that enable analysts to conduct meta analyses effectively.
It is hoped that this introduction to meta analysis will enable the reader to embark on reading, interpreting, thinking about meta analyses that can be used for their own purposes. When conducted well and appropriately, meta analyses can provide invaluable information on the comparison of different treatment approaches and exposure-outcome associations for Epidemiological studies.
